Andrea Mazzanti

Assistant Professor

University of Pavia

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Andrea Mazzanti is an Assistant Professor at the University of Pavia, Italy. His research areas include arrhythmogenic cardiomyopathies, long QT syndrome, and genetic factors influencing cardiac health. He has published extensively on topics such as genotype-specific outcomes in cardiomyopathies and innovative diagnostic tests for calcium release deficiency syndrome. His work integrates mechanistic insights with clinical applications, contributing to advancements in understanding and treating heart rhythm disorders.

Articles (27)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (17)

LUCA FRANCO PAVARINO

Università degli Studi di Pavia

ITALY

Andrea Mazzanti

Research Interests

Explore related searches

Contact this professor

About

Articles (27)

Genotype-Specific Outcomes of Desmosomal Cardiomyopathies

Genetics in arrhythmogenic cardiomyopathies: where are we now and where are we heading to?

Nutritional Factors and Arrhythmic Risk in Long QT Syndrome: A Narrative Review of Mechanistic and Clinical Evidence

Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population

Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe

A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome

Transmural APD heterogeneity determines ventricular arrhythmogenesis in LQT8 syndrome: Insights from Bidomain computational modeling

A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome

Endocardial repolarization dispersion in BrS: A novel automatic algorithm for mapping activation recovery interval

Characteristics of Patients with Spontaneous Versus Drug-Induced Brugada Electrocardiogram

Characterization of Skeletal Muscle Biopsy and Derived Myoblasts in a Patient Carrying Arg14del Mutation in Phospholamban Gene

Characterization of Skeletal Muscle Biopsy and Derived Myoblasts in a Patient Carrying Arg14del Mutation in Phospholamban Gene

Prevention of Sudden Death and Management of Ventricular Arrhythmias in Arrhythmogenic Cardiomyopathy

Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy<SUP> </SUP>

Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy

Safety and efficacy of catheter ablation for ventricular tachycardia in elderly patients with structural heart disease: a systematic review and meta-analysis

Brugada syndrome and job fitness: report of three cases

Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator

Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)

Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment—Authors' reply

Acute Myocarditis Associated With Desmosomal Gene Variants

Acute Myocarditis Associated With Desmosomal Gene Variants

Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator

Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients

Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients

Benefit of Implantable Cardioverter-Defibrillators in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia - Reply

Benefit of Implantable Cardioverter-Defibrillators in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia-Reply Response

Collaborators (17)

LUCA FRANCO PAVARINO

Jean Baptiste Gourraud

Habib Rehman Khan

Wolfgang Poller

Giacomo Tini

Julia Cadrin-Tourigny

J. Peter van Tintelen

Davide Mariani

carlo napolitano

Sung-Hwan Kim

Mingke Ni

Tanja Charlotte Frederiksen

Jacob Tfelt-Hansen

Nicolas Piriou

Cynthia James

Chetan Shenoy

Katja Zeppenfeld

Make your next move.